Share chart Bruker Corporation
Extended chart
Simple chart
About Bruker Corporation
Корпорация Bruker разрабатывает, производит и распространяет научные инструменты, а также аналитические и диагностические решения в США, Европе, Азиатско-Тихоокеанском регионе и на международном уровне. Компания работает в трех сегментах: Bruker Scientific Instruments (BSI) Life Science, BSI NANO и Bruker Energy & Supercon Technologies. more detailsMain settings
IPO date
2000-08-04
ISIN
US1167941087
Industry
Life Sciences Tools & Services
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0.5085
Дивиденд ао
0.05
Сайт
Grade
Underestimation
Title | Value | Grade |
P/S | 2.6 | 6 |
P/BV | 4.82 | 3 |
P/E | 77.33 | 1 |
Efficiency
Title | Value | Grade |
ROA | 2.25 | 1 |
ROE | 7.16 | 2 |
ROIC | 0 | 0 |
Dividends
Title | Value | Grade |
Dividend yield | 0.3937 | 0.98 |
DSI | 0.9286 | 9.29 |
Average dividend growth | 4 | 6.67 |
Debt
Title | Value | Grade |
Debt/EBITDA | 5.12 | 0 |
Debt/Ratio | 0.3867 | 10 |
Debt/Equity | 2.2 | 6 |
Growth impulse
Title | Value | Grade |
Yield Revenue, % | 69.38 | 8 |
Yield Ebitda, % | 38.36 | 5 |
Yield EPS, % | -25.88 | 0 |
Dividends
Dividend, % | Dividend | Result of period | Buy before | Register closing date | Payment before |
0.13% | 0.05 | I кв. 2025 | 13.06.2025 | 16.06.2025 | 01.07.2025 |
0.46% | 0.2 | IV кв. 2024 | 14.03.2025 | 17.03.2025 | 01.04.2025 |
0.08% | 0.05 | II кв. 2024 | 28.08.2024 | 30.08.2024 | 16.09.2024 |
0.07% | 0.05 | I кв. 2024 | 31.05.2024 | 03.06.2024 | 18.06.2024 |
0.05% | 0.05 | IV кв. 2023 | 27.02.2024 | 29.02.2024 | 15.03.2024 |
0.08% | 0.05 | II кв. 2023 | 29.08.2023 | 31.08.2023 | 15.09.2023 |
0.08% | 0.05 | III кв. 2022 | 28.11.2022 | 30.11.2022 | 15.12.2022 |
0.08% | 0.05 | II кв. 2022 | 29.08.2022 | 31.08.2022 | 15.09.2022 |
0.07% | 0.05 | IV кв. 2021 | 25.02.2022 | 28.02.2022 | 15.03.2022 |
0.06% | 0.04 | III кв. 2021 | 26.11.2021 | 30.11.2021 | 15.12.2021 |
Prices
Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
Yesterday | 39.87 $ | 0 $ | 0 $ | -1.35 % | 0 % | 0 % |
Week | 38.3 $ | 0 $ | 0 $ | 2.69 % | 0 % | 0 % |
Month | 36.34 $ | 35.5 $ | 40.66 $ | 8.23 % | 0 % | 0 % |
Three month | 41.19 $ | 35.5 $ | 44.5 $ | -4.52 % | 0 % | 0 % |
Half a year | 56.39 $ | 35.5 $ | 62.95 $ | -30.25 % | 0 % | 0 % |
Year | 63.9 $ | 35.5 $ | 70.67 $ | -38.45 % | 0 % | 0 % |
3 years | 60.03 $ | 35.5 $ | 94.27 $ | -34.48 % | 0 % | 0 % |
5 years | 42.19 $ | 35.5 $ | 94.27 $ | -6.78 % | 0 % | 0 % |
10 years | 20.89 $ | 16.43 $ | 94.27 $ | 88.27 % | 0 % | 0 % |
Year to date | 51.13 $ | 35.5 $ | 62.95 $ | -23.08 % | 0 % | 0 % |
Insider trading
Main owners
Institutions | Volume | Share, % |
T. Rowe Price Investment Management, Inc. | 13 192 344 | 9.58 |
Vanguard Group Inc | 9 896 786 | 7.19 |
Blackrock Inc. | 9 823 445 | 7.14 |
FMR, LLC | 9 432 290 | 6.85 |
Pallas Capital Advisors LLC | 8 425 357 | 6.12 |
Massachusetts Financial Services Co. | 8 080 071 | 5.87 |
RTW Investments LP | 3 344 095 | 2.43 |
State Street Corporation | 3 157 361 | 2.29 |
AllianceBernstein L.P. | 2 417 380 | 1.76 |
Invesco Ltd. | 1 984 490 | 1.44 |
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
MicroSectors Cannabis 2X Leveraged ETN | 3.3 | 88.65 | 0.95 |
Fidelity Growth Opportunities ETF | 0.38044 | -7.91 | 0.38 |
Syntax Stratified MidCap ETF | 0.15249 | -1.54 | 0.35 |
iShares Morningstar Mid-Cap Growth ETF | 0.11841 | 441.88 | 0.06 |
iShares Morningstar Mid-Cap ETF | 0.05998 | 252.83 | 0.04 |
iShares Morningstar Large-Cap Growth ETF | 0.02624 | 264.7 | 0.04 |
iShares Morningstar Large-Cap ETF | 0.01235 | 184.21 | 0.03 |
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
Mr. Gerald N. Herman | Executive VP & CFO | 858.09k | 1958 (67 years) |
Mr. Juergen Srega | President of Bruker CALID Group & Bruker Daltonics Division | 646.99k | 1955 (70 years) |
Dr. Falko Busse Ph.D. | President of Bruker BioSpin Group | 763.34k | 1967 (58 years) |
Dr. Frank H. Laukien Ph.D. | Chairman, CEO & President | 1.82M | 1960 (65 years) |
Dr. Mark R. Munch Ph.D. | Corporate Executive VP and President of Bruker Nano Group & Corporate | 1.44M | 1962 (63 years) |
Mr. Justin Joseph Ward | Senior Director of Investor Relations & Corporate Development | N/A | |
Mr. J. Brent Alldredge J.D. | General Counsel & Secretary | N/A | 1975 (50 years) |
Dr. Burkhard Prause Ph.D. | President and CEO of Bruker Energy & Supercon Technologies, Inc. | 595.96k | 1967 (58 years) |
About company
Address: United States, Billerica, 40 Manning Road - Open in google maps, Open in yandex maps
Website: http://www.bruker.com
Website: http://www.bruker.com